Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions


Ozdemir D., DAĞDELEN S., Usman A.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.17, no.4, pp.102-107, 2013 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.4274/tjem.2238
  • Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Journal Indexes: Emerging Sources Citation Index, Scopus
  • Page Numbers: pp.102-107

Abstract

Purpose: Osteoprotegerin (OPG) is a soluble decoy receptor for the receptor activator of nuclear factor kappaB ligand, thereby inhibiting bone resorption. In this study, we aimed to evaluate plasma OPG levels in patients with thyroid dysfunctions and determine whether its levels change after restoration of euthyroidism.